Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Delft

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 15, 2020
Comment on "Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines"Lieke C J van Delft, Eva van Loo, Klara Mosterd, et al.
Journal of the American Academy of Dermatology|July 8, 2018
Comment on "Guidelines of care for the management of basal cell carcinoma"Lieke C J van Delft, Maud H E Jansen, Klara Mosterd, et al.
Dermatology (Basel, Switzerland)|October 23, 2019
Single versus Multiple Level Sectioning for the Subtyping of Basal-Cell Carcinoma: A Retrospective StudyLieke C J van Delft, Patty J Nelemans, Myrurgia Abdul Hamid, et al.
The British Journal of Dermatology|January 8, 2019
Quantitative survey into value clarification of discussed treatment options among patients treated for basal cell carcinomaL C J van Delft, B A B Essers, S Harnas, et al.
BMC Psychology|July 23, 2025
The effectiveness of the Dutch juvenile diversion program Halt: study protocol for a randomized controlled trialBenthe J van Delft, Kirti Zeijlmans, Jessica J Asscher, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 12, 2002
Methodologies for bulky DNA adduct analysis and biomonitoring of environmental and occupational exposuresT M C M de Kok, H J J Moonen, J van Delft, et al.
The British Journal of Dermatology|November 1, 2020
Development of a patient decision aid for superficial basal cell carcinomaL C J van Delft, B A B Essers, P J Nelemans, et al.
The British Journal of Dermatology|December 6, 2018
The illusion of conventional histological resection margin controlL C J van Delft, P J Nelemans, E van Loo, et al.
Leukemia|October 17, 2003
Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cellsE H A Spaenij-Dekking, J Van Delft, E Van Der Meijden, et al.
Acta Dermato-Venereologica|May 15, 2026
Patient Reported Outcomes in Multidisciplinary Care for High-risk Head and Neck Cutaneous Squamous Cell CarcinomaEmmy C Cruts, Myrthe M G Moermans, Patty J Nelemans, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|January 15, 2020
Comment on "Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines"Lieke C J van Delft, Eva van Loo, Klara Mosterd, et al.
Journal of the American Academy of Dermatology|July 8, 2018
Comment on "Guidelines of care for the management of basal cell carcinoma"Lieke C J van Delft, Maud H E Jansen, Klara Mosterd, et al.
Dermatology (Basel, Switzerland)|October 23, 2019
Single versus Multiple Level Sectioning for the Subtyping of Basal-Cell Carcinoma: A Retrospective StudyLieke C J van Delft, Patty J Nelemans, Myrurgia Abdul Hamid, et al.
The British Journal of Dermatology|January 8, 2019
Quantitative survey into value clarification of discussed treatment options among patients treated for basal cell carcinomaL C J van Delft, B A B Essers, S Harnas, et al.
BMC Psychology|July 23, 2025
The effectiveness of the Dutch juvenile diversion program Halt: study protocol for a randomized controlled trialBenthe J van Delft, Kirti Zeijlmans, Jessica J Asscher, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 12, 2002
Methodologies for bulky DNA adduct analysis and biomonitoring of environmental and occupational exposuresT M C M de Kok, H J J Moonen, J van Delft, et al.
The British Journal of Dermatology|November 1, 2020
Development of a patient decision aid for superficial basal cell carcinomaL C J van Delft, B A B Essers, P J Nelemans, et al.
The British Journal of Dermatology|December 6, 2018
The illusion of conventional histological resection margin controlL C J van Delft, P J Nelemans, E van Loo, et al.
Leukemia|October 17, 2003
Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cellsE H A Spaenij-Dekking, J Van Delft, E Van Der Meijden, et al.
Acta Dermato-Venereologica|May 15, 2026
Patient Reported Outcomes in Multidisciplinary Care for High-risk Head and Neck Cutaneous Squamous Cell CarcinomaEmmy C Cruts, Myrthe M G Moermans, Patty J Nelemans, et al.
Pageof 3